6 ms·
> For those following - these treatments are 40 pill treatments. > These pills work in interesting ways, ie, generating MORE mutations. > β-d-N4-hydroxycytidi
by loeg 5y ago
> For those following - these treatments are 40 pill treatments.
> These pills work in interesting ways, ie, generating MORE mutations.
> β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells https://pubmed.ncbi.nlm.nih.gov/33961695/ https://pubmed.ncbi.nlm.nih.gov/33961695/
You're way off-base. You're talking about Merck's Molnupiravir (Lagevrio), which is both less effective (~30% vs ~88%) and already approved.
Pfizer's Paxlovid (Nirmatrelvir) is not mutagenic.
It is a 15 pill course (5 days x 3 per day), not 40.
Also, Pfizer thinks as of Nov 29 that they can make 80M courses by EOY. The US has purchased at least 10M of them.